BioCentury
ARTICLE | Company News

Management tracks

April 6, 2017 11:24 PM UTC

Sanofi (Euronext:SAN; NYSE:SNY) said David Meeker will resign as EVP of its Sanofi Genzyme unit at the end of June. The company promoted Bill Sibold to the position, effective July 1. Sibold is head of Genzyme's global multiple sclerosis oncology and immunology organization.

Protein mobility play Relay Therapeutics Inc. (Cambridge, Mass.) named Sanjiv Patel president and CEO, replacing Alexis Borisy. Patel was chief strategy officer at Allergan plc (NYSE:AGN). Borisy, a partner at Third Rock Ventures, will be Relay's chairman...